CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

FLULAVAL

RegulatoryapprovedFLULAVALPositive
AI Analysis

Summary

FLULAVAL, an influenza vaccine for persons 6 months and older, is approved for active immunization against influenza A and B viruses.

Outcome Details

FLULAVAL approved for use in persons 6 months of age and older

Importance:3/10
Sentiment:
0.50
FDA approvalinfluenza vaccineimmunization
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on July 17, 2026 10:38 AM

Read Original